Source: Business Wire

Press Release: PSG : Pharmaceutical Strategies Group Publishes Annual Drug Benefit Design Report for 2024

DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group ("PSG"), an EPIC company, released its annual Trends in Drug Benefit Design Report, sponsored by Prescryptive Health, detailing the trends and leading strategies for traditional drug benefits. The research provides valuable insights about drug benefit design and management. Management of the pharmacy benefit continues to be a critical aspect of U.S. healthcare, and this report provides insights on how healthcare payers evolve their pharma

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Dave Borden's photo - CEO of PSG

CEO

Dave Borden

CEO Approval Rating

90/100

Read more